Alemtuzumab

Monoclonal antibody

Approvedregulatory verdict

Evidence outlook

Approved: Multiple Sclerosis, Chronic Lymphocytic Leukemia

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Partial signal

Also approved (1)
EU
  • Lemtrada is indicated for adult patients with relapsing-remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.
Product first approved 2013EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (14)
Chronic Lymphocytic Leukemia
NCT00086580 · Genzyme, a Sanofi Company
2004-07 – 2010-06 · B-Cell Chronic Lymphocytic Leukemia
What this study did
Multiple Sclerosis
NCT03368664 · Genzyme, a Sanofi Company
2017-10-23 – 2025-09-08 · Multiple Sclerosis
What this study did
NCT01307332 · University of British Columbia
2011-03 – 2018-09-28 · Relapsing Remitting Multiple Sclerosis
What this study did
NCT01333358 · Central Texas Neurology Consultants
2011-05 – 2014-03 · Multiple Sclerosis
What this study did
Other / comorbidity
NCT01877837 · Hackensack Meridian Health
2011-06 – 2021-09 · Sickle Cell Disease
What this study did
NCT00646854 · Aarhus University Hospital
2008-06 – 2016-12-31 · Lymphoma, T-Cell, Peripheral
What this study did
NCT00725231 · University of Göttingen
2008-02 – 2014-03 · Peripheral T Cell Lymphoma, Unspecified, Angioimmunoblastic Lymphadenopathy, Extranodal NK/T-cell Lymphoma
What this study did
NCT00147381 · Dr. Claudia Bösmüller
2004-01 – 2011-07 · Kidney Transplantation
What this study did
NCT00316810 · Dr. Claudia Bösmüller
2006-04 – 2011-06 · Pancreas-Kidney Transplantation
What this study did
NCT00226512 · Hadassah Medical Organization
started 2004-07 · Acute Myeloid Leukemia, Myelodysplastic Syndrome
What this study did
Phase 2/3 (7)
Other / comorbidity
NCT01120028 · University of Oxford
2010-09 – 2020-03 · Kidney Transplantation
What this study did
NCT00176852 · Masonic Cancer Center, University of Minnesota
2002-06 – 2020-01 · Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia, Diamond-Blackfan Anemia, Shwachman-Diamond Syndrome
What this study did
NCT00455312 · Masonic Cancer Center, University of Minnesota
2007-08 – 2016-06 · Dyskeratosis Congenita, Aplastic Anemia
What this study did
NCT00775931 · Masonic Cancer Center, University of Minnesota
2008-08 – 2013-06 · Severe Osteopetrosis
What this study did
NCT00454480 · The University of New South Wales
2006-08 – 2012-08 · Leukemia, Myelodysplastic Syndromes
What this study did
NCT00354120 · Gruppo Italiano Trapianto di Midollo Osseo
2005-03 – 2011-08 · Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Myelofibrosis, Lympho-proliferative Diseases
What this study did
NCT00749112 · Hospital Universitario Dr. Jose E. Gonzalez
2008-08 – 2010-08 · Idiopathic Thrombocytopenic Purpura, Anemia, Hemolytic, Autoimmune
What this study did
Phase 2 (145)
Chronic Lymphocytic Leukemia
NCT01361711 · Northwestern University
2011-06 – 2027-05 · Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
What this study did
NCT04312841 · Ohio State University Comprehensive Cancer Center
2020-09-15 – 2024-04-09 · B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome, T-Cell Prolymphocytic Leukemia
What this study did
NCT01982175 · Shanghai Zhangjiang Biotechnology Limited Company
2011-07 – 2022-06 · B-cell Chronic Lymphocytic Leukemia
What this study did
NCT01392079 · University of Ulm
2008-02 – 2016-03 · Chronic Lymphocytic Leukemia
What this study did
NCT00118352 · Fred Hutchinson Cancer Center
2005-03 – 2015-05-26 · Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Juvenile Myelomonocytic Leukemia, Mast Cell Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
What this study did
NCT01013961 · ECOG-ACRIN Cancer Research Group
2011-04-27 – 2015-04-14 · Chronic Lymphocytic Leukemia
What this study did
NCT00562328 · Mayo Clinic
2008-01 – 2014-12-18 · Leukemia
What this study did
NCT00683046 · University of Chicago
2001-11 – 2014-12 · Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia, Myeloproliferative Disorder, Anemia, Aplastic, Myelodysplastic Syndromes
What this study did
NCT00504491 · CABYC
2007-07 – 2012-06 · Chronic Lymphocytic Leukaemia, Patients Resistant to a Purine Analogous, Patients Relapsed With Purines Therapy
What this study did
NCT00436904 · Mayo Clinic
2004-12 – 2011-11 · Leukemia
What this study did
NCT00147901 · German CLL Study Group
2005-01 – 2011-11 · B-cell Chronic Lymphocytic Leukemia
What this study did
NCT00230282 · Steven E. Coutre
2004-07 – 2011-10 · Leukemia, B-cell Leukemia, Chronic Leukemia, Chronic Lymphocytic Leukemia (CLL)
What this study did
NCT00328198 · Genzyme, a Sanofi Company
2006-05 – 2011-08 · B-Cell Chronic Lymphocytic Leukemia (B-CLL)
What this study did
NCT00525603 · M.D. Anderson Cancer Center
2005-06 – 2011-07 · Leukemia, Chronic Lymphocytic Leukemia
What this study did
NCT00098670 · National Cancer Institute (NCI)
2004-10 – 2011-02 · B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
What this study did
NCT01082939 · M.D. Anderson Cancer Center
2002-12 – 2011-01 · Chronic Lymphocytic Leukemia
What this study did
NCT00771602 · M.D. Anderson Cancer Center
2008-08 – 2010-12 · Chronic Lymphocytic Leukemia, Leukemia
What this study did
NCT00800943 · Chronic Lymphocytic Leukemia Research Consortium
2003-12 – 2010-08 · B-Cell Chronic Lymphocytic Leukemia
What this study did
NCT00004857 · Alliance for Clinical Trials in Oncology
2000-01 – 2010-02 · Leukemia
What this study did
NCT00278213 · German CLL Study Group
2002-09 – 2009-12 · Prolymphocytic Leukemia
What this study did
NCT00040846 · Fred Hutchinson Cancer Center
2001-11 – 2009-12 · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Peripheral T-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Progressive Hairy Cell Leukemia, Initial Treatment, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Splenic Marginal Zone Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenström Macroglobulinemia
What this study did
NCT00274976 · German CLL Study Group
2002-09 – 2009-08 · Leukemia
What this study did
NCT00143065 · Ohio State University Comprehensive Cancer Center
2005-08 – 2009-07 · Lymphoma, Small Lymphocytic, Lymphocytic Leukemia, Chronic
What this study did
NCT00337519 · Charite University, Berlin, Germany
2003-01 – 2009-04 · Chronic Lymphocytic Leukemia
What this study did
NCT00206726 · Genzyme, a Sanofi Company
2005-05 – 2008-04 · Leukemia, Lymphocytic, Chronic, B-Cell
What this study did
NCT00565981 · Arbeitsgemeinschaft medikamentoese Tumortherapie
2004-03 – 2008-02-13 · B-cell Chronic Lymphocytic Leukemia
What this study did
NCT00458523 · Leeds Cancer Centre at St. James's University Hospital
2006-12 – 2008-02 · Leukemia
What this study did
NCT00071396 · M.D. Anderson Cancer Center
2002-10 – 2007-08 · Chronic Lymphocytic Leukemia
What this study did
NCT00102661 · M.D. Anderson Cancer Center
2002-10 – 2006-09 · Chronic Lymphocytic Leukemia
What this study did
NCT00162851 · Karolinska University Hospital
2003-04 – 2006-07 · B-CLL
What this study did
NCT00006390 · Eastern Cooperative Oncology Group
2001-07-05 – 2004-12 · Leukemia
What this study did
Multiple Sclerosis
NCT01679041 · Seah Lim M.D.
2012-11 – 2013-11 · Multiple Sclerosis
What this study did
NCT00050778 · Genzyme, a Sanofi Company
2002-12 – 2010-01 · Multiple Sclerosis, Relapsing-Remitting
What this study did
Other / comorbidity
NCT06358638 · Children's National Research Institute
2024-04-03 – 2054-09 · Sickle Cell Disease
What this study did
NCT07616154 · St. Jude Children's Research Hospital
2026-09-10 – 2035-09 · Sickle Cell Disease
What this study did
NCT01659606 · Boston Children's Hospital
2012-07 – 2034-12 · Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome, Revesz Syndrome, Aplastic Anemia
What this study did
NCT04339777 · National Cancer Institute (NCI)
2020-09-22 – 2032-11-30 · Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases, Common Variable Immunodeficiency, Primary T-cell Immunodeficiency Disorders
What this study did
NCT06872333 · Masonic Cancer Center, University of Minnesota
2024-11-19 – 2032-06-01 · Graft Failure, Sickle Cell Disease, Hemoglobinopathies
What this study did
NCT03587272 · Robert Nickel
2018-04-17 – 2030-11 · Sickle Cell Disease
What this study did
NCT04362293 · St. Jude Children's Research Hospital
2020-04-30 – 2029-08-01 · Sickle Cell Disease
What this study did
NCT03579875 · Masonic Cancer Center, University of Minnesota
2018-11-13 – 2029-01-05 · Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes, T Cell Receptor Alpha/Beta Depletion, Telomere Biology Disorder, Bone Marrow Failure, Dyskeratosis Congenita, Telomere Biology Disorders
What this study did
NCT04232085 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2020-02-12 – 2028-12-31 · Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure, Short Telomere Length, Fanconi Anemia, Non Fanconi DNA-DSB Repair Disorder, Hoyeraal-Hreidarsson Syndrome, Dyskeratosis Congenita, Telomere Biology Disorder, Short Telomere Syndrome
What this study did
NCT05501756 · Children's Hospital Medical Center, Cincinnati
2023-01-11 – 2028-08-31 · Allogeneic Hematopoietic Cell Transplantation
What this study did
NCT03630211 · Paul Szabolcs
2018-07-31 – 2028-08-01 · Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension
What this study did
NCT03214354 · University of Calgary
2017-07-05 – 2028-07 · Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, Pure Red Cell Aplasia
What this study did
NCT02105766 · National Heart, Lung, and Blood Institute (NHLBI)
2014-04-21 – 2027-12-31 · Sickle Cell Disease, Thalassemia, Stem Cell Transplantation, Graft vs Host Disease
What this study did
Phase 1/2 (54)
Chronic Lymphocytic Leukemia
NCT00935792 · Mayo Clinic
2009-07 – 2015-12 · Lymphocytic Leukemia
What this study did
NCT01269385 · Mayo Clinic
2011-01 – 2015-06 · B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia
What this study did
NCT00951457 · Arbeitsgemeinschaft medikamentoese Tumortherapie
2009-03 – 2012-08-06 · Leukemia, Lymphocytic, Chronic, B-Cell
What this study did
NCT00634881 · German CLL Study Group
2003-11 – 2012-02-17 · Chronic Lymphocytic Leukemia
What this study did
NCT00281983 · German CLL Study Group
2000-06 – 2010-07 · Chronic Lymphocytic Leukemia
What this study did
Multiple Sclerosis
NCT01712945 · Cambridge University Hospitals NHS Foundation Trust
2012-06 – 2017-10 · Multiple Sclerosis
What this study did
Other / comorbidity
NCT07599176 · National Heart, Lung, and Blood Institute (NHLBI)
2026-07-08 – 2035-06-30 · Sickle Cell Disease, Beta-thalassemia
What this study did
NCT06851767 · National Institute of Allergy and Infectious Diseases (NIAID)
2025-05-09 – 2034-12-31 · X-linked Severe Combined Immunodeficiency, X-SCID, XSCID
What this study did
NCT05463133 · National Institute of Allergy and Infectious Diseases (NIAID)
2022-07-08 – 2032-12-31 · Chronic Granulomatous Disease
What this study did
NCT06325709 · National Institute of Allergy and Infectious Diseases (NIAID)
2024-04-17 – 2032-12-31 · Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease
What this study did
NCT01306019 · National Institute of Allergy and Infectious Diseases (NIAID)
2012-09-25 – 2032-12-31 · X-linked Severe Combined Immunodeficiency (XSCID)
What this study did
NCT00920972 · Washington University School of Medicine
2001-12 – 2031-12 · Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Non-malignant Disorders
What this study did
NCT01499888 · University of Illinois at Chicago
2011-11-11 – 2029-10 · Sickle Cell Disease
What this study did
NCT02629120 · National Institute of Allergy and Infectious Diseases (NIAID)
2015-12-17 – 2028-12-30 · Chronic Granulomatous Disease Transplant
What this study did
NCT03500731 · Paul Szabolcs
2018-04-19 – 2028-12 · Idiopathic Pulmonary Fibrosis, Emphysema or COPD
What this study did
NCT03653338 · Paul Szabolcs
2018-08-02 – 2028-08-01 · Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia
What this study did
NCT00061568 · National Heart, Lung, and Blood Institute (NHLBI)
2004-07-16 – 2028-01-20 · Congenital Hemolytic Anemia, Sickle Cell Disease
What this study did
NCT00692939 · Paul Szabolcs
2012-06-26 – 2027-12 · Crohn's Disease
What this study did
NCT06959771 · National Institute of Allergy and Infectious Diseases (NIAID)
2025-07-16 – 2027-10-28 · CD40L-HyperIgM Syndrome
What this study did
NCT05357482 · National Heart, Lung, and Blood Institute (NHLBI)
2022-05-12 – 2027-01-31 · Sickle Cell Anemia, Beta Thalassemia
What this study did
NCT00977691 · National Heart, Lung, and Blood Institute (NHLBI)
2009-12-14 – 2026-09-10 · Sickle Cell Anemia
What this study did
NCT03077542 · National Heart, Lung, and Blood Institute (NHLBI)
2017-04-06 – 2026-08-31 · Sickle Cell Disease
What this study did
NCT02061800 · Diane George
2013-06-03 – 2026-07 · Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)
What this study did
NCT03182426 · University of Alberta
2017-08-15 – 2024-07-15 · Diabetes Mellitus, Type 1
What this study did
NCT02059239 · Weill Medical College of Cornell University
2014-06-04 – 2020-06-15 · Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
What this study did
NCT02472054 · Assistance Publique - Hôpitaux de Paris
2015-06-29 – 2020-05-20 · Hemophagocytic Lymphohistiocytosis (HLH)
What this study did
NCT02435901 · Northwell Health
2008-12 – 2019-12 · Sickle Cell Disease, Beta Thalassemia-Major
What this study did
NCT00047060 · National Heart, Lung, and Blood Institute (NHLBI)
2002-07-30 – 2019-01-24 · Mycosis Fungoides, Sezary Syndrome
What this study did
NCT00520130 · National Cancer Institute (NCI)
2007-10-30 – 2018-12-31 · Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease, Acute Leukemia, Multiple Myeloma
What this study did
NCT00943319 · University of Chicago
2012-03 – 2018-12 · Leukemia, Lymphoma, Myeloma
What this study did
NCT01875237 · M.D. Anderson Cancer Center
2013-12-27 – 2017-03-07 · Leukemia, Myeloma, Myeloproliferative Diseases
What this study did
NCT00453427 · Ontario Clinical Oncology Group (OCOG)
2006-09 – 2015-05 · Peripheral T-cell Lymphomas
What this study did
NCT01446484 · Pirogov Russian National Research Medical University
2011-10 – 2014-11 · End-Stage Renal Disease, Kidney Failure
What this study did
NCT00058825 · Baylor College of Medicine
2000-08 – 2014-09 · Hematologic Malignancies
What this study did
NCT00943592 · University of Chicago
2006-03 – 2013-11 · Advanced Hematologic Malignancies, Leukemia, Preleukemia
What this study did
NCT00061945 · National Cancer Institute (NCI)
2003-06 – 2012-10 · Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00167661 · University of Wisconsin, Madison
2004-06 – 2012-05 · Disorder Related to Renal Transplantation
What this study did
NCT00983528 · University of California, San Diego
2009-09 – 2011-09 · Acute Lymphoblastic Leukemia
What this study did
NCT00773149 · Assistance Publique - Hôpitaux de Paris
2006-10 – 2011-07 · Acute Lymphocytic Leukemia
What this study did
NCT00363090 · Toronto Sunnybrook Regional Cancer Centre
2006-09 – 2010-12 · Lymphoma
What this study did
NCT00579111 · Baylor College of Medicine
2007-06 – 2010-10 · Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders, Hematologic Diseases
What this study did
NCT00555048 · Fred Hutchinson Cancer Center
2007-09 – 2010-10 · Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
What this study did
NCT00078559 · University of Wisconsin, Madison
2003-11 – 2010-02 · Kidney Transplantation, Kidney Disease
What this study did
NCT00626626 · Milton S. Hershey Medical Center
2007-05 – 2010-01 · Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma
What this study did
NCT00579137 · Baylor College of Medicine
2007-10 – 2009-10 · Severe Combined Immunodeficiency Disease, Severe Primary Immunodeficiency Disorder, Undefined T Cell Deficiency Disorder, Wiskott-Aldrick Syndrome
What this study did
NCT00590460 · Baylor College of Medicine
2001-07 – 2009-09 · Fanconi Anemia, Severe Aplastic Anemia
What this study did
NCT00801931 · Columbia University
2007-09-06 – 2009-05-05 · Leukemia, Lymphoma, Neuroblastoma, Immunodeficiencies, Anemia
What this study did
NCT00085449 · Alliance for Clinical Trials in Oncology
2006-05 – 2007-01 · Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
What this study did
NCT00056966 · Baylor College of Medicine
2002-11 – 2006-12 · Hematologic Malignancy
What this study did
NCT00077961 · Genzyme, a Sanofi Company
2003-12 – 2006-02 · Non-Hodgkin's Lymphoma
What this study did
Phase 1 (36)
Chronic Lymphocytic Leukemia
NCT00330252 · Dana-Farber Cancer Institute
2006-05 – 2014-01 · Chronic Lymphocytic Leukemia
What this study did
NCT00947388 · Case Comprehensive Cancer Center
2008-11 – 2013-03 · Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma
What this study did
NCT00923182 · Genzyme, a Sanofi Company
2010-02 – 2011-08 · Leukemia, Lymphocytic, Chronic, B-Cell
What this study did
Multiple Sclerosis
NCT02583594 · Genzyme, a Sanofi Company
2015-12-06 – 2021-03-01 · Progressive Multiple Sclerosis
What this study did
NCT01624714 · Samuel Forrester Hunter, MD, PhD
2012-09 – 2017-09 · Multiple Sclerosis
What this study did
Other / comorbidity
NCT03910452 · National Institute of Allergy and Infectious Diseases (NIAID)
2019-10-28 – 2034-06-15 · Chronic Granulomatous Disease
What this study did
NCT07015684 · Columbia University
2025-04-28 – 2032-03-12 · Sickling Disorder Due to Hemoglobin S
What this study did
NCT05384756 · City of Hope Medical Center
2022-07-13 – 2026-12-01 · Sickle Cell Disease
What this study did
NCT03504241 · National Institute of Allergy and Infectious Diseases (NIAID)
2018-07-30 – 2025-09-16 · Kidney Transplantation, Renal Transplantation, Renal Transplant Recipient
What this study did
NCT03989466 · M.D. Anderson Cancer Center
2020-01-15 – 2024-09-24 · Recurrent T-Cell Prolymphocytic Leukemia, T-Cell Prolymphocytic Leukemia
What this study did
NCT02867800 · Monica Bhatia
2016-07 – 2023-12-30 · Sickle Cell Disease, Graft Versus Host Disease
What this study did
NCT03421756 · Kathleen Dorritie
2018-03-29 – 2022-05-15 · Sickle Cell Disease
What this study did
NCT02678143 · Washington University School of Medicine
2016-04-26 – 2021-11-16 · Sickle Cell Disease
What this study did
NCT02689453 · National Cancer Institute (NCI)
2017-01-19 – 2021-06-15 · T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL), Cutaneous T Cell Lymphoma (CTCL), T-Cell Prolymphocytic Leukemia
What this study did
NCT01625351 · St. Jude Children's Research Hospital
2012-08-20 – 2020-02-10 · Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma
What this study did
NCT00426517 · National Institute of Allergy and Infectious Diseases (NIAID)
2007-01-19 – 2019-11-01 · Inherited Immune Deficiencies
What this study did
NCT03132584 · Dana-Farber Cancer Institute
2017-07-30 – 2018-01-30 · Non Hodgkin Lymphoma, High-grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma
What this study did
NCT02653196 · Montefiore Medical Center
2015-09 – 2017-08 · Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell Transplantation
What this study did
NCT00323323 · Ohio State University Comprehensive Cancer Center
2004-03 – 2016-10 · Non-Hodgkin's Lymphoma
What this study did
NCT00578266 · Mayo Clinic
2007-02 – 2016-08-16 · Anemia, Aplastic
What this study did
NCT00278512 · Northwestern University
2003-08 – 2016-06 · Vasculitis
What this study did
NCT00282412 · Northwestern University
2002-09 – 2016-06 · Rheumatoid Arthritis
What this study did
NCT00214214 · University of Wisconsin, Madison
started 2005-10 · New Onset Type 1 Diabetes Mellitus
What this study did
NCT00881556 · Columbia University
2009-08-20 – 2015-09 · Epidermolysis Bullosa
What this study did
NCT00495755 · Dana-Farber Cancer Institute
2007-07 – 2012-10 · Chronic Graft-vs.-Host Disease
What this study did
NCT00943293 · University of Chicago
2003-05 – 2012-01 · Preleukemia, Myeloproliferative Disorders, Lymphoma, Myeloma, Graft Versus Host Disease
What this study did
NCT00637390 · University of Michigan Rogel Cancer Center
2008-03 – 2010-10 · Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
What this study did
NCT00057005 · Baylor College of Medicine
2003-02 – 2009-10 · LEUKEMIA
What this study did
NCT00586274 · Baylor College of Medicine
2002-03 – 2009-07 · FANCONI ANEMIA
What this study did
NCT00562068 · Cancer Research UK
2007-05 – 2009-05 · Lymphoma, Small Intestine Cancer
What this study did
NCT00161590 · Weill Medical College of Cornell University
started 2004-07 · T-Cell Lymphoma, Lymphoma, Non-Hodgkin's
What this study did
NCT00684255 · New York Medical College
2007-08 – 2008-07 · Systemic Lupus Erythematosus, Systemic Sclerosis
What this study did
NCT00104975 · Yale University
2005-02 – 2008-05 · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
What this study did
NCT00458250 · Tehran University of Medical Sciences
2006-09 – 2008-02 · Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute
What this study did
NCT00152100 · St. Jude Children's Research Hospital
2004-02 – 2007-08 · Severe Combined Immunodeficiency
What this study did
NCT00113048 · Genzyme, a Sanofi Company
2003-12 – 2005-09 · Hematologic Malignancies
What this study did
Phase 4 (18)
Multiple Sclerosis
NCT03135249 · University of Texas Southwestern Medical Center
2018-05-01 – 2020-11-04 · Multiple Sclerosis (MS)
What this study did
NCT02419378 · University Hospital Muenster
2015-06 – 2020-11 · Multiple Sclerosis, Relapsing-Remitting
What this study did
NCT02255656 · Genzyme, a Sanofi Company
2015-01-07 – 2020-07-15 · Relapsing Remitting Multiple Sclerosis
What this study did
NCT03784898 · Genzyme, a Sanofi Company
2019-02-08 – 2019-12-11 · Multiple Sclerosis
What this study did
NCT01395316 · University of Chicago
2011-06 – 2017-07 · Multiple Sclerosis
What this study did
NCT02205489 · Genzyme, a Sanofi Company
2014-10 – 2016-04 · Relapsing-remitting Multiple Sclerosis
What this study did
Other / comorbidity
NCT01729494 · University of Cincinnati
2012-09 – 2019-12 · Renal Transplantation
What this study did
NCT01757574 · Johns Hopkins University
2012-11 – 2016-08 · Chronic Inflammatory Demyelinating Neuropathy
What this study did
NCT01405807 · Cambridge University Hospitals NHS Foundation Trust
2011-02 – 2014-03 · Vasculitis, Microscopic Polyangiitis, Granulomatosis With Polyangiitis, Wegener's
What this study did
NCT00331162 · Wake Forest University Health Sciences
2005-02 – 2011-11-28 · Graft Rejection
What this study did
NCT01172418 · University of Miami
2006-02 – 2010-05 · Transplant; Failure, Kidney
What this study did
NCT00166712 · Northwestern University
2005-04 – 2010-04 · Kidney Transplant Failure and Rejection
What this study did
NCT01213329 · Northwestern University
2006-02 – 2009-04 · Kidney Transplant
What this study did
NCT00113269 · Astellas Pharma Inc
2005-05 – 2009-03 · Kidney Transplantation
What this study did
NCT01046955 · University of Miami
2005-11 – 2008-12 · End-Stage Renal Disease, Living Donors
What this study did
NCT00681343 · University of Miami
2002-09 – 2007-10 · Living-Donor Kidney Transplant
What this study did
NCT00177138 · University of Minnesota
2004-07 – 2006-11 · Diabetes Mellitus
What this study did
NCT00685061 · University of Miami
2002-11 – 2005-09 · Renal Transplantation
What this study did
Early phase / not applicable (22)
Chronic Lymphocytic Leukemia
NCT00587847 · Northwell Health
2005-08 – 2009-11 · Chronic Lymphocytic Leukemia
What this study did
NCT00336206 · Tawam Hospital
2006-07 – 2009-10 · B-Cell Chronic Lymphocytic Leukemia
What this study did
NCT00021151 · Case Comprehensive Cancer Center
2000-01 – 2002-05 · Leukemia
What this study did
Multiple Sclerosis
Other / comorbidity
NCT01652092 · Masonic Cancer Center, University of Minnesota
2012-09-04 – 2026-12 · SCID, Omenn's Syndrome, Reticular Dysgenesis, Wiskott-Aldrich Syndrome, Bare Lymphocyte Syndrome, Common Variable Immunodeficiency, Chronic Granulomatous Disease, CD40 Ligand Deficiency, Hyper IgM Syndrome, X-linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Griscelli Syndrome, Chediak-Higashi Syndrome, Langerhan's Cell Histiocytosis
What this study did
NCT02162420 · Masonic Cancer Center, University of Minnesota
2015-01-10 – 2025-03-11 · Dyskeratosis Congenita, Aplastic Anemia
What this study did
NCT00619528 · Northwestern University
2008-01 – 2023-09 · Immunosuppression, Kidney Transplantation, Graft Rejection
What this study did
NCT03302754 · Children's Hospital Medical Center, Cincinnati
2017-10-05 – 2019-03-10 · Allogeneic Hematopoietic Cell Transplantation
What this study did
NCT00578292 · Baylor College of Medicine
2004-02 – 2016-05 · Thalassemia
What this study did
NCT01408342 · Hospital Universitario Dr. Jose E. Gonzalez
2011-07 – 2014-01 · Aplastic Anemia
What this study did
NCT01626092 · Masonic Cancer Center, University of Minnesota
2012-07-11 – 2013-11 · Lysosomal Storage Disease, Peroxisomal Disorder
What this study did
NCT00578539 · Baylor College of Medicine
2007-10 – 2013-05 · Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloproliferative Disorders
What this study did
NCT00578344 · Tami D. John
2005-07 – 2012-07 · Sickle Cell Disease, Hemoglobin SC
What this study did
NCT01042509 · Hospital Universitario Dr. Jose E. Gonzalez
2009-10 – 2012-01 · Graft vs Host Disease
What this study did
NCT00038844 · M.D. Anderson Cancer Center
2001-06 – 2010-09 · Lymphoma, Leukemia
What this study did
NCT00525876 · M.D. Anderson Cancer Center
2005-01 – 2010-09 · Lymphoma
What this study did
NCT00214201 · University of Wisconsin, Madison
2003-05 – 2009-05 · Primary Renal Transplant
What this study did
NCT02711202 · Institute for Clinical and Experimental Medicine
2007-01 – 2009-03 · Kidney Transplantation
What this study did
NCT00582894 · University of Oklahoma
2005-02 – 2008-03 · Hematological Neoplasms, Hematopoietic Stem Cell Transplantation
What this study did
NCT00579592 · University of Wisconsin, Madison
2006-04 – 2007-04 · Acute Rejection, Renal Transplantation
What this study did
NCT00038883 · M.D. Anderson Cancer Center
2001-04-09 – 2006-05 · Leukemia, Lymphocytic, Chronic, Leukemia, Lymphocytic, Acute, Lymphoma, Low-Grade, Lymphoma, T-Cell, Lymphoma, B-Cell
What this study did
Used as active comparator (6)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (2)
Multiple Sclerosis
NCT03477500 · Haukeland University Hospital
2018-03-21 – 2028-03-21 · Multiple Sclerosis
What this study did
Other / comorbidity
NCT00564512 · French Innovative Leukemia Organisation
2007-11 – 2013-07 · Leukemia
What this study did
Phase 2/3 (1)
Other / comorbidity
NCT01019876 · Columbia University
2002-09 – 2021-09-07 · Bone Marrow Failure, Osteopetrosis, Fanconi Anemia, Severe Combined Immunodeficiency
What this study did
Phase 2 (2)
Chronic Lymphocytic Leukemia
NCT00871546 · Merck Sharp & Dohme LLC
2009-03 – 2010-12 · Lymphoma, Mantle-Cell, Leukemia, Lymphocytic, Chronic, B-Cell
What this study did
Multiple Sclerosis
NCT04971005 · Universitätsklinikum Hamburg-Eppendorf
2021-08-27 – 2022-02-04 · Relapsing-Remitting Multiple Sclerosis
What this study did
Phase 4 (1)
Other / comorbidity
NCT00246129 · EMagnusson
2005-10 – 2011-06 · Kidney Transplantation, Kidney Diseases, Kidney Failure
What this study did
Appears in other studies (2)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 1/2 (1)
Other / comorbidity
NCT00183248 · University of Miami
2004-09 – 2009-11 · Kidney Transplantation, Kidney Disease, Kidney Failure
What this study did
Early phase / not applicable (1)
Multiple Sclerosis
NCT03500328 · Johns Hopkins University
2018-05-02 – 2026-08-31 · Multiple Sclerosis, Relapsing-Remitting
What this study did

Competitive landscape

This drug's own stage for Chronic Lymphocytic Leukemia: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Alemtuzumab: this drugApprovedMonoclonal antibodyCD52not yet gradedNo reviewed efficacy summary in this indication
AcalabrutinibApprovedSmall moleculeBTKPartial signalFeatured results are non-efficacy only in this race
IbrutinibApprovedSmall moleculeBTKPartial signal
NCT01611090: Progression-free Survival (PFS) (Up to 5 years): Ibrutinib+BR 65.12 Months | Placebo+BR 14.32 Months (95% CI 13.86 to 16.62)
ObinutuzumabApprovedMonoclonal antibodyCD20Partial signalNo reviewed efficacy summary in this indication
PF-05280586ApprovedBiologic (subtype unspecified)CD20not yet gradedNo reviewed efficacy summary in this indication
PirtobrutinibApprovedSmall moleculeBTKPartial signalFeatured results are non-efficacy only in this race
Rituximab (Rituxan)ApprovedMonoclonal antibodyCD20, CD20-directed Cytolytic Antibodynot yet gradedNo reviewed efficacy summary in this indication
Rituximab-Abbs (Truxima)ApprovedMonoclonal antibodyCD20not yet gradedNo reviewed efficacy summary in this indication
VenetoclaxApprovedSmall moleculeBCL-2Partial signal
NCT02005471: Investigator-assessed PFS, venetoclax-rituximab vs bendamustine-rituximab: 2-year rates 84.9% vs 36.3% (hazard ratio 0.17; P<0.001)
Zanubrutinib (Brukinsa)ApprovedSmall moleculeBTKPartial signal
NCT03734016: Overall response rate, zanubrutinib (n=327) vs ibrutinib (n=325): by independent review 86.2% vs 75.7%, response ratio 1.14 (95% CI 1.05 to 1.22), non-inferiority p<0.0001, superiority p=0.0007; by investigator 83.5% vs 74.2%, response ratio 1.12 (95% CI 1.04 to 1.22), non-inferiority p<0.0001, superiority p=0.0035 (CT.gov posted results).
BexobrutidegPhase 3Small moleculeBruton's tyrosine kinase (BTK)not yet gradedNo reviewed efficacy summary in this indication
NemtabrutinibPhase 3Small molecule—not yet gradedNo reviewed efficacy summary in this indication
Sonrotoclax (Beqalzi)Phase 3Small moleculeBCL-2not yet gradedNo reviewed efficacy summary in this indication
MesutoclaxPhase 2/3Small moleculeBCL-2not yet gradedNo reviewed efficacy summary in this indication
MS-553Phase 1/2Small moleculeProtein kinase C-beta (PKC-beta)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(29 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Alemtuzumab to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (6)
November 2026 (2)
Phase 2Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias …Recruiting
Est. primary completion 2026-11 · NCT01962415 · CT.gov ↗
What to watch
Phase 2Sickle Cell DiseaseActive not recruiting
Est. primary completion 2026-11 · NCT04018937 · CT.gov ↗
What to watch
December 2026 (4)
Phase 1/2Crohn's DiseaseRecruiting
Est. primary completion 2026-12 · NCT00692939 · CT.gov ↗
What to watch
Phase 1/2Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Non-malignant DisordersRecruiting
Est. primary completion 2026-12 · NCT00920972 · CT.gov ↗
What to watch
Phase 2Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome, Revesz Syndrome, Aplastic AnemiaActive not recruiting
Est. primary completion 2026-12 · NCT01659606 · CT.gov ↗
What to watch
Phase 1Sickle Cell DiseaseActive not recruiting
Est. primary completion 2026-12-01 · NCT05384756 · CT.gov ↗
What to watch
2027 (6)
January 2027 (1)
Phase 2Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes, T Cell Receptor Alpha/Beta Depletion, Telomere Biology Disorder …Recruiting
Est. primary completion 2027-01-01 · NCT03579875 · CT.gov ↗
What to watch
October 2027 (1)
Phase 1/2CD40L-HyperIgM SyndromeRecruiting
Est. primary completion 2027-10-28 · NCT06959771 · CT.gov ↗
What to watch
December 2027 (4)
Phase 1/2Idiopathic Pulmonary Fibrosis, Emphysema or COPDRecruiting
Est. primary completion 2027-12 · NCT03500731 · CT.gov ↗
What to watch
Phase 1/2Chronic Granulomatous Disease TransplantActive not recruiting
Est. primary completion 2027-12-30 · NCT02629120 · CT.gov ↗
What to watch
Phase 2Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure, Short Telomere Length, Fanconi Anemia …Recruiting
Est. primary completion 2027-12-31 · NCT04232085 · CT.gov ↗
What to watch
Phase 2Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum, Pseudomyxoma PeritoneiNot yet recruiting
Est. primary completion 2027-12-31 · NCT06084780 · CT.gov ↗
What to watch
2028 (6)
July 2028 (1)
Phase 2Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, Pure Red Cell AplasiaRecruiting
Est. primary completion 2028-07 · NCT03214354 · CT.gov ↗
What to watch
August 2028 (3)
Phase 1/2Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan AnemiaRecruiting
Est. primary completion 2028-08-01 · NCT03653338 · CT.gov ↗
What to watch
Phase 2Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary HypertensionRecruiting
Est. primary completion 2028-08-01 · NCT03630211 · CT.gov ↗
What to watch
Phase 2Allogeneic Hematopoietic Cell TransplantationRecruiting
Est. primary completion 2028-08-31 · NCT05501756 · CT.gov ↗
What to watch
September 2028 (1)
Phase 1/2Sickle Cell DiseaseActive not recruiting
Est. primary completion 2028-09-23 · NCT01499888 · CT.gov ↗
What to watch
October 2028 (1)
Phase 2Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases, Common Variable Immunodeficiency …Recruiting
Est. primary completion 2028-10-01 · NCT04339777 · CT.gov ↗
What to watch
2030 (3)
March 2030 (1)
Phase 1Sickling Disorder Due to Hemoglobin SRecruiting
Est. primary completion 2030-03-12 · NCT07015684 · CT.gov ↗
What to watch
June 2030 (1)
Phase 2Graft Failure, Sickle Cell Disease, HemoglobinopathiesRecruiting
Est. primary completion 2030-06-01 · NCT06872333 · CT.gov ↗
What to watch
November 2030 (1)
Phase 2Sickle Cell DiseaseRecruiting
Est. primary completion 2030-11 · NCT03587272 · CT.gov ↗
What to watch
2032 (4)
June 2032 (1)
Phase 1/2Sickle Cell Disease, Beta-thalassemiaRecruiting
Est. primary completion 2032-06-30 · NCT07599176 · CT.gov ↗
What to watch
December 2032 (3)
Phase 1/2Chronic Granulomatous DiseaseRecruiting
Est. primary completion 2032-12-31 · NCT05463133 · CT.gov ↗
What to watch
Phase 1/2Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous DiseaseRecruiting
Est. primary completion 2032-12-31 · NCT06325709 · CT.gov ↗
What to watch
Phase 1/2X-linked Severe Combined Immunodeficiency (XSCID)Recruiting
Est. primary completion 2032-12-31 · NCT01306019 · CT.gov ↗
What to watch
2034 (3)
June 2034 (1)
Phase 1Chronic Granulomatous DiseaseActive not recruiting
Est. primary completion 2034-06-15 · NCT03910452 · CT.gov ↗
What to watch
September 2034 (1)
Phase 2Sickle Cell DiseaseRecruiting
Est. primary completion 2034-09 · NCT07616154 · CT.gov ↗
What to watch
December 2034 (1)
Phase 1/2X-linked Severe Combined Immunodeficiency, X-SCID, XSCIDEnrolling by invitation
Est. primary completion 2034-12-31 · NCT06851767 · CT.gov ↗
What to watch
2044 (1)
September 2044 (1)
Phase 2Sickle Cell DiseaseRecruiting
Est. primary completion 2044-09 · NCT06358638 · CT.gov ↗
What to watch

See the full readout calendar ↗